A frequent chromosomal translocation in mature B-cell non-Hodgkin lymphoma affects band 3q27 and results in the deregulation of the B-cell lymphoma 6 (BCL6) gene. Two breakpoint clusters have been described thus far, the major breakpoint region (MBR) and an alternative breakpoint region (ABR) that is located 245-285 kb 5 0 to BCL6. Translocation at the MBR predominates in diffuse large B-cell lymphoma, whereas translocation at the ABR is reported to be frequently associated with grade 3B follicular lymphoma. However, translocation at the ABR has not been studied in a large series of follicular lymphomas, particularly t(14;18)-negative follicular lymphomas. Therefore, we studied BLC6 rearrangements at the MBR and ABR by using breakapart fluorescence in situ hybridization (FISH) probes in 142 cases of follicular lymphomas, including 63 t(14;18)-negative and 79 t(14;18)-positive cases. Conventional cytogenetic (karyotype) analysis was also performed in 58 of the 63 t(14;18)-negative cases. BCL6 rearrangement was found in 26% of t(14;18)-negative and 19% of t(14;18)-positive follicular lymphoma. t(14;18)-negative cases showed a high frequency of rearrangement at the ABR (12%) with an ABR/MBR ratio of 0.86, compared with only 5% with an ABR/MBR ratio of 0.36 in the t(14;18)-positive cases. BCL6 rearrangements were found in all grades of follicular lymphoma but were most frequent in grade 3 t(14;18)-negative follicular lymphoma (60%). FISH analysis had a higher sensitivity for detecting BCL6 rearrangements than conventional cytogenetics. In conclusion, BCL6 rearrangements occur at a similar frequency in t(14;18)-negative follicular lymphoma and diffuse large B-cell lymphoma. However, t(14;18)-negative follicular lymphoma appears to have a higher frequency of rearrangement at the ABR compared with t(14;18)-positive follicular lymphoma and diffuse large B-cell lymphoma. Therefore, it is important to perform FISH analysis with ABR to determine possible involvement of BCL6 rearrangement in follicular lymphoma, especially in t(14;18)-negative cases.
Follicular lymphoma is a neoplasm of germinal center B cells and comprises about 20% of all lymphomas with the highest incidence in the United States and Western Europe. It affects primarily adults, with a median age in the sixth decade and a male/female ratio of 1:1.7.
1 Follicular lymphoma is generally considered to be an indolent, but incurable disease, with a median overall survival of 7-10 years. Transformation to an aggressive B-cell lymphoma occurs in about 25-35% of cases and is associated with a poor outcome. 1 A chromosomal translocation, t(14;18)(q32;q21), is the genetic hallmark of follicular lymphoma. This translocation can be identified in 85-90% of nodal follicular lymphoma cases. 2 Juxtaposition of the B-cell leukemia/lymphoma 2 gene (BCL2) at chromosome 18q21 and the immunoglobulin heavy chain gene (IgH) at 14q32 results in the deregulation of BCL2, an antiapoptotic protein. Additional genetic alterations result in progression to follicular lymphoma. 3, 4 However, 10-15% of cases do not harbor the t(14;18)(q32;q21) and in these t(14;18)-negative cases, other mechanisms are thought to be involved in the pathogenesis.
A frequent chromosomal translocation in mature B-cell lymphoma is a rearrangement affecting chromosomal band 3q27, which results in the deregulation of expression of BCL6, a human proto-oncogene. 5, 6 BCL6 encodes a 95 kd nuclear zinc-finger phosphoprotein, which functions as a sequence-specific transcriptional repressor. 7 Chromosome 3q27 rearrangement/BCL6 translocation is frequently found in diffuse large B-cell lymphoma, at a frequency of 25-37%, depending on the detection methods used and patient population studied. [8] [9] [10] BCL6 translocations have also been reported at a lower frequency in follicular lymphoma (13 and 14.3%). 8, 10 The highest frequency of BCL6 translocation has been reported in grade 3B follicular lymphoma (44%). 11 Interestingly, a higher frequency of 3q27 abnormalities (22%) was also found in t(14;18)-negative follicular lymphoma, 12, 13 including the t(3;14)(q27;q32), suggesting an important role for BCL6 in t(14;18)-negative follicular lymphoma. 12, 13 In addition to translocation at the major breakpoint region (MBR) that encompasses the noncoding first exon and part of the first intron of BCL6, an alternative breakpoint region (ABR) located 245-285 kb 5 0 to BCL6 has been described. 14, 15 Translocations of BCL6 involving the ABR were reported to be associated with grade 3B follicular lymphoma. 16 However, translocation at the ABR has not been examined in a large series of follicular lymphoma, particularly in t(14;18)-negative cases. The aim of this study was to determine the frequency of BCL6 rearrangements at the MBR and ABR in a series of well-defined t(14;18)-negative and t(14;18)-positive follicular lymphoma cases. We have used breakapart fluorescence in situ hybridization (FISH) probes for the MBR and ABR of BCL6. The splitting of the FISH signals could be caused by many different cytogenetic rearrangements occurring in that region, including translocations, inversions and insertions; we will therefore use the term 'rearrangement' for all subsequent discussions. We also compared these results with our previously published study of diffuse large B-cell lymphoma. 17 
Materials and methods

Patient Population
We selected 142 cases of follicular lymphoma ( 
FISH Analysis
Interphase FISH analysis for BCL6 rearrangements was performed on the 142 cases using tissue microarrays made from formalin-fixed, paraffinembedded tissue blocks, as described earlier. 17 Briefly, hematoxylin and eosin-stained sections from each tissue block were used to define diagnostic areas, and three representative 0.6-mm cores were obtained from each case. Only follicular lymphoma components were selected for FISH studies in the composite lymphomas cases. A BCL6 break-apart probe (Abbott-Vysis, Downers Grove, IL, USA) was used to detect BCL6 rearrangement at the MBR, and a home-brew break-apart probe (Clones RP11-1144D2 and RP11-76L15, kindly provided by WL Lam and RJ deLeeuw) was used for rearrangement at the ABR (Figure 1 ). Nuclei were counterstained with 4,6-diamidino-2-phenylindole (DAPI) in Antifade solution and the slides were visualized using an Olympus BX51 fluorescence microscope. Images were captured and archived using CytoVision software (Applied Imaging, Santa Clara, CA, USA). To analyze the hybridization, a total of 50 -100 nuclei per case were scored for the presence of the BCL6 rearrangement. A cutoff for positive FISH assays for both the MBR and ABR was established to be more than 20%. Interphase FISH analysis for BCL2 rearrangement was also performed using a BCL2 break-apart probe (Abbott-Vysis, Downers Grove, IL, USA) with a positive cutoff of 20%. Any ambiguous FISH results 
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Conventional Cytogenetic Analysis
Karyotypes were available in 58 of the 63 t(14;18)-negative follicular lymphoma cases. Cytogenetic analysis was performed according to a previously described protocol. 18 When available, at least 20 metaphases were analyzed. Karyotypes of Giemsabanded chromosomes were described according to the International System for Human Cytogenetic Nomenclature (ISCN 2005).
Statistical Analysis
Fisher's exact test was used to calculate P-value in the statistical analysis.
Results
Sixty-three t(14;18)-negative cases of follicular lymphoma had a median age of 62 years (range, 24-86 years; 59% female and 41% male). BCL2 rearrangement status was verified by BCL2 FISH analysis in all t(14;18)-negative follicular lymphoma cases. A total of 112 FISH assays for the BCL6 rearrangements yielded interpretable results, including 63 MBR and 49 ABR studies. There were a total of 79 t(14;18)-positive cases of follicular lymphoma with a median age 55 years (range, 34-89 years; 48% female and 52% male). In these t(14;18)-positive cases, a total of 117 FISH assays for the BCL6 rearrangements yielded interpretable results, including 79 MBR and 38 ABR studies. A higher technical failure rate was noted in BCL6 ABR FISH studies.
The frequency of the BCL6 rearrangement was 26% in t(14;18)-negative follicular lymphoma (BCL6-MBR: 14%, BCL6-ABR: 12%) and 19% in t(14;18)-positive follicular lymphoma (BCL6-MBR: 14%, BCL6-ABR: 5%) ( Table 1) . We found that t(14;18)-negative follicular lymphoma appeared to have a higher frequency of rearrangement at the ABR with an ABR/MBR ratio of 0.86, compared with t(14;18)-positive follicular lymphoma (ABR/MBR ratio of 0.36) and diffuse large B-cell lymphoma (ABR/MBR ratio of 0.32). 17 There was no statistically significant difference detected in the distribution of BCL6-ABR rearrangement positive cases between the two groups (t(14;18)-negative and t(14;18)-positive cases) (P ¼ 0.46).
A comparison of clinical features, histological grade and the rearrangement status of BCL6 in the t(14;18)-negative and t(14;18)-positive follicular lymphoma is listed in Table 2 . The t(14;18)-negative follicular lymphoma group contains a higher frequency of grade 3 cases than t(14;18)-positive follicular lymphoma group (57 vs 37%, P ¼ 0.02). BCL6 rearrangements were found in all grades of follicular lymphoma, but were the highest in grade 3 t(14;18)-negative follicular lymphoma cases (60%) ( Table 2 ).
The distribution of BCL6 rearrangement was analyzed in grade 3 follicular lymphoma cases, particularly in grade 3 cases with a diffuse large Bcell lymphoma component. Owing to higher technical failure rate in the BCL6 ABR FISH analysis, only 49 t(14;18)-negative follicular lymphoma cases had interpretable FISH assays for the BCL6-MBR and BCL6-ABR rearrangements, and only two cases were grade 3B, both of which also contained a diffuse large B-cell component. One (case no. 15, Table 3 ) had a BCL6-MBR rearrangement. Twentyeight of the 49 cases were grade 3A and half of the 28 cases had a diffuse large B-cell component. Among these 14 cases, one had BCL6-ABR rearrangement and four had BCL6-MBR rearrangement (Table 3) .
Similarly, in the 38 t(14;18)-positive follicular lymphoma cases with interpretable FISH assays for both the BCL6-MBR and BCL6-ABR rearrangements, only two cases were grade 3B, both of which also contained a diffuse large B-cell lymphoma component, and one of these two cases had a BCL6-MBR rearrangement. Twelve of the 38 cases were grade 3A and 3 of the 12 cases had a diffuse large B-cell lymphoma component, and one of these three cases had a BCL6-ABR rearrangement. Thus, none of the follicular lymphoma 3B cases studied had BCL6-ABR rearrangement. The numbers of positive cases in each group are too small for statistical analysis. 
Discussion
Chromosomal translocation involving band 3q27 (BCL6) is common in diffuse large B-cell lymphoma and is recognized to be pathogenetically significant. 19 This translocation is also seen in other B-cell non-Hodgkin lymphoma, mainly in follicular lymphoma, but also in marginal zone lymphoma. 20 However, most studies of BCL6 translocation by FISH or Southern blot analysis in follicular lymphoma did not include probe(s) for the BCL6-ABR rearrangement. [8] [9] [10] 13 Translocation at the ABR has been reported to occur more frequently in follicular lymphoma (2/20, 10%) than in diffuse large B-cell lymphoma (2/84, 2.4%). 15 This finding questions the reported incidence of BCL6 translocation, especially in follicular lymphoma when the ABR was not (Table 1) . Using FISH analysis, Diaz-Alderete et al 21 also reported similar frequencies of BCL6 rearrangement at the MBR in t(14;18)-negative (14.6%) and t(14;18)-positive follicular lymphoma (13.1%). In addition, we found that the frequency of BCL6 rearrangement at the ABR appeared to be higher in t(14;18)-negative (12%) than in t(14;18)-positive follicular lymphoma (5%) ( Table 1) . There is only a trend that t(14;18)-negative follicular lymphomas are associated with a higher frequency of BCL6-ABR rearrangement, although there was no statistically significant difference for this rearrangement between t(14;18)-negative cases and t(14;18)-positive cases due to the overall low incidence of BCL6 rearrangements at the MBR and ABR.
The BCL6-ABR rearrangement occurred in all grades of follicular lymphoma but was most frequent in grade 3 t(14;18)-negative follicular lymphoma cases (67%) ( Table 2 ). In a smaller series, Bosga-Bouwer et al 16 selected eight cases of grade 3B follicular lymphoma with cytogenetic abnormalities at the 3q27 and reported that the ABR translocation was found in six of these cases. However, in our series of 87 follicular lymphoma cases with interpretable FISH assays for both the BCL6-MBR and BCL6-ABR rearrangements, none of the four cases of grade 3B follicular lymphoma (2 t(14;18)-negative and two t(14;18)-positive) had a BCL6-ABR rearrangement. Although BCL6 rearrangement was common in grade 3 follicular lymphoma, especially in t(14;18)-negative cases, we did not observe a high frequency in grade 3B cases. However, the number of 3B follicular lymphoma is small and this issue needs further investigation.
We also found the overall frequency of BCL6 rearrangement in t(14;18)-negative follicular lymphoma (26%) to be similar to that of our previously published study for diffuse large B-cell lymphoma cases (25%), 17 suggesting that BCL6 may also be pathogenetically significant in t(14;18)-negative follicular lymphoma. However, t(14;18)-negative follicular lymphoma had a higher frequency of BCL6 rearrangement at the ABR, whereas diffuse large Bcell lymphoma more frequently used the MBR. We found that the intergenic region around the ABR is actively transcribed, with transcripts found in germinal center B-cell lines but not in cell lines at other stages of B-cell differentiation (data not shown). The chromatin structure in germinal center B cells may, therefore, permit rearrangements to occur at this location. However, why this region is preferentially used in t(14;18)-negative follicular lymphoma and the mechanism of rearrangement is not currently understood.
The mechanism of dysregulation of BCL6 expression due to BCL6 rearrangement at the MBR has been extensively investigated. Chromosomal translocations at the MBR place the intact coding region of BCL6 under the control of heterologous promoters derived from partner chromosomes, resulting in deregulated expression of BCL6. [22] [23] [24] Moreover, most rearrangements at the MBR remove the first noncoding exon of the BCL6 gene that contains two BCL6-binding sites, and thus disrupt a negative autoregulatory circuit. 25, 26 Some of the rearrangements may also disrupt an interferon regulatory factor 4 (IRF4) responsive region in the first intron of BCL6 and block its downregulation by CD40 signaling. 27 In contrast, chromosomal rearrangements at the ABR leave the regulatory regions intact in the first exon and first intron of BCL6. Thus, rearrangement at the ABR must introduce a strong enhancer signal to dysregulate BCL6 expression. It has been reported that diffuse large B-cell lymphoma and follicular lymphoma cases with ABR rearrangement expressed BCL6 at levels comparable with phenotypically similar cases with MBR rearrangement or with no 3q27 abnormality. 15 It should be noted that the dysregulation of BCL6 expression may also result from mutations introduced by the somatic hypermutation mechanism affecting the 5 0 regulatory region of BCL6, as noted above. 25 Thus, the frequency of cases with dysregulated BCL6 expression may be significantly higher than the frequency of cases with BCL6 rearrangement. Also, rearranged cases with a preserved 5 0 regulatory region may be further affected by these mutations.
Discrepancies between FISH analysis and conventional cytogenetics (karyotype study) were not infrequent in our study. The possible explanations include: (1) 3q27 rearrangements not involving the MBR and ABR regions, (2) compromised morphology of tumor chromosomes making it difficult to recognize rearrangements near the telomeric end of 3q, (3) the rearrangement involving 3q27 are hidden in partially characterized karyotypes containing 'add' (additional uncharacterized chromosomal material) or 'marker' chromosomes. 28 In summary, our study shows that the frequency of the BCL6 rearrangement is similar in t(14;18)-negative follicular lymphoma and diffuse large B-cell lymphoma. However, t(14;18)-negative follicular lymphoma has a higher frequency of BCL6 rearrangement at the ABR, whereas t(14;18)-positive follicular lymphoma and diffuse large B-cell lymphoma more frequently use the MBR than the ABR. Therefore, it is important to include the ABR for FISH analysis of BCL6 rearrangements in follicular lymphoma, especially in t(14;18)-negative cases.
The high frequency of BCL6 rearrangement in t(14;18)-negative follicular lymphoma suggests that BCL6 could play an important role in the lymphomagenesis. The mechanism of BCL6 rearrangement at the ABR is currently under investigation and may explain the differential usage of this breakpoint in the different lymphomas. How rearrangements at the far 5 0 ABR affect BCL6 expression is intriguing and requires further study.
